Company / R&D per Share
MARAVAI LIFESCIENCES HOLDINGS, INC. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.13
FY2025
5-year range
$0.06 / $0.64
FY2021-FY2025
Trend
+75.2%
vs FY2024
Sector context
#200 of 208
Health Care
What the data says
Among 208 Health Care companies, MARAVAI LIFESCIENCES HOLDINGS, INC. is in the bottom 4% for r&d per share. R&D per Share has fluctuated over the past 7 years, ranging from $0.01 in FY2019 to $0.64 in FY2022.
Based on SEC 10-K filings.
0.13 in FY2025 with a 5-year CAGR of -16.3%.
Improved from $0.07 to $0.13 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -40.8%
- 5-Year CAGR
- -16.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 208This company $0.13 Sector average $28.82
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 75.2% year-over-year.
- Ranks #200 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | +75.2% |
| FY2024 | $0.08 | +12.3% |
| FY2023 | $0.07 | -89.5% |
| FY2022 | $0.64 | +960.2% |
| FY2021 | $0.06 | -81.4% |
| FY2020 | $0.32 | +2153.2% |
| FY2019 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026